Inotiv, Inc. (NOTVQ) vs T2 Biosystems, Inc. (TTOO)

Inotiv, Inc. and T2 Biosystems, Inc. are both Diagnostics & Research companies. T2 Biosystems, Inc. is the larger, with a market value of $6.5M against $2.8M — 2.3× the size. Inotiv, Inc. grew revenue faster over the last twelve months: 5.61% against −30.2%. Inotiv, Inc. has the higher net margin (−17.1% vs −559.5%) and the lower return on invested capital (−6.19% vs 0.00%). Across the 16 metrics below, Inotiv, Inc. leads on 8 and T2 Biosystems, Inc. on 8.

Valuation

Metric NOTVQ TTOO Diagnostics & Research median
P/E n/m n/m 35.56
P/S 0.00 n/m 4.37
P/B 0.00 n/m 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA 60.99 n/m 24.35
EV/Sales 1.57 6.26 5.51
Earnings yield (25,300.00%) 0.00% (1.89%)
Free cash flow yield (2,858.05%) 0.00% (0.15%)

Profitability

Metric NOTVQ TTOO Diagnostics & Research median
Gross margin 22.94% (76.76%) 50.89%
Operating margin (9.48%) (542.59%) (8.57%)
Net margin (17.14%) (559.52%) (6.37%)
Free cash flow margin (1.95%) (476.64%) 0.00%
Return on equity (74.09%) 277.61% (2.92%)
Return on assets (11.85%) (140.00%) (6.71%)
Return on invested capital (6.19%) 0.00% 0.00%

Growth

Metric NOTVQ TTOO Diagnostics & Research median
Revenue growth (TTM) 5.61% (30.19%) 7.69%
EPS growth (last fiscal year) 49.64% 98.44% 25.92%
Revenue growth, 5-year CAGR 53.36% (7.29%) 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NOTVQ TTOO Diagnostics & Research median
Debt to equity 5.49 0.00 0.11
Current ratio 0.27 0.40 2.02
Net debt to EBITDA 12.68 0.32 0.70

Dividend

Metric NOTVQ TTOO Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric NOTVQ TTOO Diagnostics & Research median
Market cap 2.79m 6.48m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack